Independent research, involving over 3 million Italians, conducted by Henley Management College and the University of Milan has concluded that the prescription costs for men over the age of 65 is significantly higher than it is for women. The study is published in the July 4th issue of the online, open-access journal PLoS ONE.
The primary objective of this study was to make the first step in the modelling of pharmaceutical demand in Italy to improve the governance of prescribing funds.
The research found that the mean annual prescription cost per individual was similar for males (196.13 euro) and females (195.12euro). However after 65 years of age, the mean prescribing costs for males were significantly higher than females. On average, costs for a 75-year-old man would be 12 times the costs for a 25-34 year-old subject if male, 8 times if female. Subjects over 65 years of age (22% of total population) accounted for 56% of total prescribing costs.
This research is able to pinpoint the future resources required by the Italian Regional Health Authorities according to the demographics of specific regional populations.
Source: Public Library of Science
Related stories:
Free drug samples may burden patients' pockets
Following free drug sample receipt, patients who receive these samples have significantly higher out-of-pocket prescription costs than those who don't, according to the first study to look at the out-of-pocket cost associated with free-sample use, published in the March 24, 2008, issue of
Medical Care.
Asthma medicines often not prescribed as national guidelines recommend
More than a decade after national guidelines were issued for asthma treatment, some patients still don’t receive prescriptions for the inhalers that experts say offer the safest and most effective long-term control of the disease, a new study suggests.
Prescription costs rise more than 6 times when patients reach 65 says study of 5M people
Prescribing costs increase dramatically when people reach 65, according to a detailed analysis of more than five million patients published in the March issue of the
British Journal of Clinical Pharmacology.
Study suggests LF elimination program is 'best buy in public health'
A study published today concludes that in the ten years since its initiation, the international effort to eliminate lymphatic filariasis (LF) has made a large impact towards ridding the world of one of its most debilitating diseases. The analysis found that the LF elimination programme has prevented 6.6 million children from acquiring LF and stopped another 9.5 million people already infected with the disease from progressing to more debilitating stages. These efforts are the result of the most rapid scale-up of a drug administration programme in public health history, delivering what the study calls a "best buy in public health".
Genetic finding implicates innate immune system in major cause of blindness
Scientists have identified one of the genes implicated in age-related macular degeneration, the most common cause of blindness in developed countries.
CRC screening before Medicare age could save millions in federal health-care dollars
A screening program for colon cancer in patients starting ten years prior to Medicare eligibility, at age 55 instead of Medicare's 65, would save at least two dollars for every dollar spent, according to a new study presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando.
Where you live matters when you're seriously ill
America does a mediocre job caring for its sickest people. The nation, says a new report, gets a C.
Compared to all commercial carriers, log truckers have better safety record
A report on the log truck industry just delivered to the state legislature indicates that the number of traffic accidents involving log trucks declined 11 percent while collisions for all commercial trucks increased by 15 percent in Washington between 2004 and 2006.